Henan Cancer Hospital: all 234 studies
Page 2 of 3. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.
- Lenvatinib for Advanced Bone and Soft Tissue SarcomaRecruitingNCT05617859Phase 2
- Application of Antiosteoporosis Therapy in OsteolysisNot yet recruitingNCT05617846
- Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone TumorsNot yet recruitingNCT05616195
- Application of LARS Ligament in Bone Prosthesis ReplacementNot yet recruitingNCT05616182
- Cryoablation for Advanced Bone and Soft Tissue TumorsRecruitingNCT05615545
- Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During PerichemotherapyNot yet recruitingNCT05598827Not applicable
- Application of Douyin in Perioperative Period of Malignant Tumor PatientsNot yet recruitingNCT05598229Not applicable
- Long-term Follow-up of Anxiety and Depression in Patients With Malignant TumorsRecruitingNCT05596344
- Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05495152Phase 3
- Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid TumorRecruitingNCT05490667Not applicable
- Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT05490485Phase 2
- Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue TumorsRecruitingNCT05468970
- PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced MelanomaRecruitingNCT05466474Phase 2
- Study on Clinical Features, Treatment Mode and Survival of SarcomaRecruitingNCT05453409
- Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast CancerRecruitingNCT05398861Phase 2
- Camrelizumab Combined With Apatinib MesylateRecruitingNCT05380986Not applicable
- AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung CancerRecruitingNCT05377658Phase 2
- Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast CancerRecruitingNCT05296577Phase 2
- Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaRecruitingNCT05276167Not applicable
- Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System LymphomaRecruitingNCT05209620Phase 2
- Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.RecruitingNCT05189483Phase 2
- Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.Not yet recruitingNCT05162898Not applicable
- Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerRecruitingNCT05063136Phase 3
- Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS LymphomaRecruitingNCT04938297Phase 2
- Toripalimab Plus FLOT in Locally Advanced Gastric CancerRecruitingNCT04891016Phase 2
- Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System LymphomaRecruitingNCT04737889Phase 2
- A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast CancerRecruitingNCT04547907Phase 3
- Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal CarcinomaRecruitingNCT04280822Phase 3
- Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in LymphomaRecruitingNCT04263935
- Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)RecruitingNCT04138212Phase 3
- Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06888531Phase 2
- First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic RadiotherapyStatus unknownNCT06586697Phase 2
- Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast CancerActive, not recruitingNCT06394661Phase 2
- RD13-02 for Patients With r/r CD7+ T Cell Hematologic MalignanciesCompletedNCT05923541Early Phase 1
- Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue SarcomaStatus unknownNCT05747521Not applicable
- Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different GenotypesStatus unknownNCT05608785Phase 1/2
- A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ TrastuzumabStatus unknownNCT05583383Not applicable
- Neoadjuvant Chemotherapy Compared With Surgery for Esophageal CarcinomaCompletedNCT05569668
- Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung CancerStatus unknownNCT05547737
- Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of RecurrenceStatus unknownNCT05545124Phase 2
- Application of Painting Analysis and Psychotherapy in Children With Bone TumorsCompletedNCT05475938Not applicable
- A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast CancerWithdrawnNCT05474690Phase 3
- A Study on the Potential Benefit of Neoadjuvant Therapy for AGC PatientsStatus unknownNCT05442138
- A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast CancerCompletedNCT05394285Phase 2
- Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)Status unknownNCT05359120
- Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain MetastasesStatus unknownNCT05357417Phase 2
- Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor FailureTerminatedNCT05335473Phase 1/2
- Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)Active, not recruitingNCT05328440Phase 2
- RC48 Plus AK105 and Cisplatin in Advanced Gastric CancerStatus unknownNCT05313906Phase 2
- Utidelone in Third-line and Above Treatment of Small Cell Lung CancerStatus unknownNCT05299255Phase 2
- Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative GastrectomyStatus unknownNCT05282563Not applicable
- An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
- Anti-emetic Prophylaxis With or Without DexamethasoneCompletedNCT05242874Phase 3
- PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.Status unknownNCT05207735Phase 2
- Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric CancerActive, not recruitingNCT05177068Phase 2
- Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast CancerTerminatedNCT05176080Phase 1/2
- PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell LymphomaTerminatedNCT05083208Phase 1
- Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal CancerStatus unknownNCT05023720
- TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.Status unknownNCT05013697Phase 2
- Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric AdenocarcinomaStatus unknownNCT04948125Phase 2
- Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung CancerStatus unknownNCT04901754Phase 2
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)Status unknownNCT04778800Not applicable
- Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal CancerCompletedNCT04718038
- Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.Status unknownNCT04681287Phase 2
- Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric CancerStatus unknownNCT04675866Not applicable
- Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell LymphomaSuspendedNCT04668365Phase 2
- Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBCCompletedNCT04664972Phase 2
- Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerCompletedNCT04660097Phase 2
- A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System TumorsStatus unknownNCT04615312Phase 1
- Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder CancerCompletedNCT04553939Phase 2
- GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound PaclitaxelWithdrawnNCT04538833Phase 2
- VR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaCompletedNCT04433156Phase 2
- the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic ChemotherapyStatus unknownNCT04430361Phase 2
- PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric AdenocarcinomaStatus unknownNCT04341857Phase 2
- Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLCStatus unknownNCT04331626Phase 4
- Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast CancerStatus unknownNCT04293276Phase 2
- L-TIL in Patients With Malignancy Resistance to Anti-PD-1 TherapyStatus unknownNCT04268108
- Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04229849Phase 2
- Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride CapsuleCompletedNCT04223583Phase 4
- A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel NeurotoxicityCompletedNCT04222790Phase 2
- R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell LymphomaCompletedNCT04214626Phase 2
- SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast CancerStatus unknownNCT04213898Phase 1/2
- Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung CancerStatus unknownNCT04199559Phase 1/2
- Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer PatientsWithdrawnNCT04199520Phase 2
- An Immunogenic Personal Neoantigen Vaccine for Cancer TreatmentStatus unknownNCT04087252Phase 1
- Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's LymphomaActive, not recruitingNCT04067037Phase 2
- Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.Status unknownNCT04063683Phase 2
- Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLCCompletedNCT04055792Phase 2
- Study of CT and MR in the Lung CancerStatus unknownNCT04034667
- Study of CT and MR in the Gastric CancerStatus unknownNCT04028375
- Apatinib Plus SHR1210 in Advanced Mucosal MelanomaStatus unknownNCT03986515Phase 2
- Teripalimab Plus Chemotherapy in Local Advanced Esophageal CancerStatus unknownNCT03985670Phase 2
- Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung CancerStatus unknownNCT03983759Phase 2
- Treatment of Advanced Gastrointestinal Tumors With Albumin TaxolStatus unknownNCT03977077Not applicable
- Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 AntibodyStatus unknownNCT03975036Phase 2/3
- Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 TypeStatus unknownNCT03963193Phase 2
- Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric CancerStatus unknownNCT03954756Phase 2
- SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT03950271Phase 2
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Status unknownNCT03947242Not applicable